The effect of Losartan on chronic allograft nephropathy

WANG Pingxian; et al

doi:10.13406/j.cnki.cyxb.2004.05.024

您当前的位置：

首页 >

文章列表页 >

The effect of Losartan on chronic allograft nephropathy

更新时间：2024-01-17

- The effect of Losartan on chronic allograft nephropathy
- Journal of Chongqing Medical University Issue 5, Pages: 641-643(2004)
- 作者机构：
  
  1. 第三军医大学附属新桥医院泌尿外科
  2. 第三军医大学附属新桥医院泌尿外科,重庆,400037
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2004.05.024
  CLC： R699.2
- Published：2004，
扫描看全文
[1]王平贤,王安静,张艮甫,黄赤兵,范明齐,冯嘉瑜,肖亚,方针强.血管紧张素Ⅱ受体拮抗剂治疗慢性移植物肾病[J].重庆医科大学学报,2004(05):641-643.

WANG Pingxian, et al. The effect of Losartan on chronic allograft nephropathy. [J]. Journal of Chongqing Medical University (5):641-643(2004)
[1]王平贤,王安静,张艮甫,黄赤兵,范明齐,冯嘉瑜,肖亚,方针强.血管紧张素Ⅱ受体拮抗剂治疗慢性移植物肾病[J].重庆医科大学学报,2004(05):641-643. DOI： 10.13406/j.cnki.cyxb.2004.05.024.

WANG Pingxian, et al. The effect of Losartan on chronic allograft nephropathy. [J]. Journal of Chongqing Medical University (5):641-643(2004) DOI： 10.13406/j.cnki.cyxb.2004.05.024.

摘要

目的 :探讨血管紧张素Ⅱ受体拮抗剂氯沙坦能否改善慢性移植物肾病患者的肾功能。方法 :对病理诊断为慢性移植物肾病早期肾功不全的 18例患者（组Ⅰ ）使用洛沙坦治疗 1年以上

与同期内未使用氯沙坦的 2 3例慢性移植物肾病患者（组Ⅱ ）进行对比

比较两组的肾功能、血和尿TGF - β1浓度及使用氯沙坦的不良反应等。结果 :治疗 1年后

组Ⅰ有 12例（6 7% ）患者移植肾功能得以好转或不再继续恶化

而组Ⅱ除 4例（17% ）移植肾功能维持在原有水平外

其他患者肾功能均进行性恶化。组Ⅰ血和尿TGF - β1浓度及肾功损失量均明显低于组Ⅱ

使用洛沙坦无不良反应发生。结论 :氯沙坦能改善部分慢性移植物肾病患者的肾功能

其药理作用可能与降低移植肾内TGF -pl的分泌有关。

Abstract

Objective:To determine the efficacy of losartan a specific angiotensin Ⅱ receptor antagonist

in improving renal function among renal transplant recipients with chronic allograft nephropathy(CAN).Methods:18 renal transplant recipients with CAN (group Ⅰ)were treated with losartan for at least one year.Another 23 patients with CAN (group Ⅱ) while not treated with losartan were used as control in the same period.Renal function

blood and urine TGF-β 1 concentration were compared between the two groups.Results:One year later

there were 12 patients (67.0%) with stabilized or improved graft function in group Ⅰ

and 4 patients (17.0%) in group Ⅱ.The difference was significant.Blood and urine TGF-β 1 concentration and renal function lost were lower m group Ⅰ than in group Ⅱ.No side effects were noted in all patients in group Ⅰ.Conclusion:Losartan can improve renal fimction among renal transplant recipients with chronic allograft nephropathy through reducing TGF-β 1 secretion in the kidney.

关键词

肾移植肾病氯沙坦

Keywords

kidney transplantationNephropathyLosartan

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

HE CHANG OF BMD IN OLD AND MIDDLE AGE PATIENTS WITH DIABETIC NEPHROPATHY AND ITS SIDNIFICANCE PROBING

Influence of CTLA4Ig combined with rapamycin on the survival of renal allografts in rats

The significance of anti-intrarenal artery spasm in renal allografts with unknown ischemia

Analysis an cause and treatment of ureteral stenosis in early period after kidney transplantation

Establishment of the rat model of chronic allograft nephropathy

Related Author

张万钟

严钟德

郭常辉

方针强

贾维胜

肖亚

冯嘉渝

王平贤

Related Institution

第三军医大学附属新桥医院泌尿外科肾移植中心

Department of Urology,Xinqiao Hospital,the Third Military Medical University

重庆医科大学附属第二医院泌尿外科

Department of Urology,the Second Affiliated Hospital,Chongqing Medical University

⁰